X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs DISHMAN PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH DISHMAN PHARMA STERLING BIOTECH/
DISHMAN PHARMA
 
P/E (TTM) x -1.8 25.1 - View Chart
P/BV x 0.1 3.3 2.0% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 STERLING BIOTECH   DISHMAN PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
DISHMAN PHARMA
Mar-16
STERLING BIOTECH/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs11374 2.8%   
Low Rs3129 2.6%   
Sales per share (Unadj.) Rs26.8197.8 13.6%  
Earnings per share (Unadj.) Rs-15.021.2 -70.5%  
Cash flow per share (Unadj.) Rs-5.534.7 -15.7%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs54.9179.9 30.5%  
Shares outstanding (eoy) m267.8780.69 332.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.3 20.4%   
Avg P/E ratio x-0.511.9 -3.9%  
P/CF ratio (eoy) x-1.37.2 -17.6%  
Price / Book Value ratio x0.11.4 9.1%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m1,86220,306 9.2%   
No. of employees `0001.40.8 163.3%   
Total wages/salary Rs m5475,355 10.2%   
Avg. sales/employee Rs Th5,303.319,252.7 27.5%   
Avg. wages/employee Rs Th403.86,459.5 6.3%   
Avg. net profit/employee Rs Th-2,959.02,064.1 -143.4%   
INCOME DATA
Net Sales Rs m7,18115,961 45.0%  
Other income Rs m43265 16.1%   
Total revenues Rs m7,22316,226 44.5%   
Gross profit Rs m9474,103 23.1%  
Depreciation Rs m2,5431,091 233.2%   
Interest Rs m4,377944 463.5%   
Profit before tax Rs m-5,9312,334 -254.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924624 -308.6%   
Profit after tax Rs m-4,0071,711 -234.1%  
Gross profit margin %13.225.7 51.3%  
Effective tax rate %32.426.7 121.4%   
Net profit margin %-55.810.7 -520.4%  
BALANCE SHEET DATA
Current assets Rs m14,33511,018 130.1%   
Current liabilities Rs m49,8099,517 523.4%   
Net working cap to sales %-494.09.4 -5,253.4%  
Current ratio x0.31.2 24.9%  
Inventory Days Days403110 365.1%  
Debtors Days Days17135 489.8%  
Net fixed assets Rs m55,43216,304 340.0%   
Share capital Rs m268161 166.0%   
"Free" reserves Rs m13,93512,907 108.0%   
Net worth Rs m14,70114,516 101.3%   
Long term debt Rs m9,4784,189 226.2%   
Total assets Rs m73,98829,805 248.2%  
Interest coverage x-0.43.5 -10.2%   
Debt to equity ratio x0.60.3 223.4%  
Sales to assets ratio x0.10.5 18.1%   
Return on assets %0.58.9 5.6%  
Return on equity %-27.311.8 -231.2%  
Return on capital %-6.417.5 -36.7%  
Exports to sales %25.924.8 104.5%   
Imports to sales %0.23.7 4.5%   
Exports (fob) Rs m1,8603,956 47.0%   
Imports (cif) Rs m12596 2.0%   
Fx inflow Rs m1,8604,952 37.6%   
Fx outflow Rs m25697 3.6%   
Net fx Rs m1,8354,255 43.1%   
CASH FLOW
From Operations Rs m1,7192,786 61.7%  
From Investments Rs m-3,148-1,529 205.9%  
From Financial Activity Rs m1,426-941 -151.5%  
Net Cashflow Rs m-3316 -1.1%  

Share Holding

Indian Promoters % 33.9 61.4 55.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 9.9 12.7 78.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 22.1 177.8%  
Shareholders   21,482 46,261 46.4%  
Pledged promoter(s) holding % 55.9 35.8 156.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  MERCK LTD  GSK PHARMA  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 18, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS